NanoTemper Brings Spectral Shift Technology to the Protein Production Market With Andromeda X, Enabling Biopharma and CROs to Increase Efficiency of Expression Screening for Recombinant Protein Targets
2024年5月6日 - 10:17PM
ビジネスワイヤ(英語)
NanoTemper Technologies, well known for creating biophysical
tools that accelerate the work of drug discovery researchers,
brings their groundbreaking Spectral Shift technology to the
protein production market with the release of Andromeda X, an
instrument that determines optimal expression alongside thermal
stability of recombinant proteins in crude lysates. Andromeda X
increases the efficiency of protein production teams at Biopharma
and CROs, who now have the ability to optimize purification schemes
for challenging, low-yield targets much faster, and with
unprecedented insights on thermal stability during expression
screening.
“At NanoTemper, our vision of creating a world where every
disease is treatable starts here, in early drug development.
Without high-quality drug targets or protein therapeutics,
researchers cannot realize this vision. So, we’ve adapted our
reliable and trusted optics systems to provide valuable insights
for those working to express and purify these critical targets,”
says Dr. Philipp Baaske, co-CEO of NanoTemper.
Dr. Amit Gupta, Head of Product Management at NanoTemper, adds,
“Andromeda X incorporates our Spectral Shift optics, which are
precision engineered to be sensitive enough to reveal expression
levels and stability characterization from small batch crude
lysates before teams commit to a purification scheme. Andromeda X
gives expression insights in less time than traditional SDS-PAGE
gels and provides additional information on the foldedness and
functionality of the recombinant proteins.”
With Andromeda X, protein production teams can now hand over
high-quality recombinant proteins faster and save themselves the
trouble of re-screening or chasing unpromising leads by assessing
the stability of proteins early on. Andromeda provides all of the
valuable information needed to help them quickly and efficiently
select for conditions that result in expression of quality
proteins.
Visit nanotempertech.com/andromeda to find out more details.
About NanoTemper Technologies
At NanoTemper, our vision is to help create a world where every
disease is treatable. For us, that starts by equipping scientists
with reliable biophysical tools that bring them the clarity,
confidence, and momentum they need to discover and develop future
therapies, even difficult ones. Because the path to a disease-free
world requires courage, big thinking, and collaboration, we’ll
continue to create innovative products that meet the needs of our
customers as they face new and difficult challenges.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240503533952/en/
John Valdez, Director of Marketing
john.valdez@nanotempertech.com 415.670.0424